Obesity
Latest News
Can We Repurpose Obesity Drugs to Reverse Liver Disease?
A new retrospective observational study offers evidence that GLP-1 RAs may have a direct impact on MASLD,...
Conference Coverage
ATA: Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Researchers compared medical records of adults with type 2 diabetes and moderate cardiovascular risk who were new users of GLP-1 receptor agonists...
Commentary
Lifestyle Medicine Trends to Keep an Eye On
“What we truly need is a patient-centered approach that restores health by addressing not just diagnoses but also the physical, emotional, and...
Conference Coverage
Weight Loss Surgery, Obesity Drugs Achieve Similar Results but Have Different Safety Profiles
Although all interventions were associated with reductions in percentage total weight loss compared with placebo, RYGB led to the greatest...
Feature
Should the Body Roundness Index Replace BMI?
Several studies have suggested that BRI could be a valuable tool for assessing health risks.
Commentary
Cardiovascular Disease 2050: No, GLP-1s Won’t Save the Day
Harvard Medical School professor tells “where we will be in 2050” if prior trends remain the same.
Latest News
Humans and Carbs: A Complicated 800,000-Year Relationship
On one hand, the human body needs and craves carbs to function but on the other hand, the modern glut of nutritionally barren carbs in not healthy...
From the Journals
Does Exercise Intensity Modulate Ghrelin?
Total ghrelin levels were significantly lower during high-intensity exercise than during moderate-intensity and no exercise.
Commentary
Help Your Patients Reap the Benefits of Plant-Based Diets
What if we focus on decreasing dietary restrictions, incorporating a variety of nourishing foods, and educating our patients, instead of on...
Commentary
Is CGM the New CBT?
Continuous glucose monitoring can help patients through a “carrot and stick” approach to dieting.
Expert Interview
How Are Doctors Using Tirzepatide vs Semaglutide? A Q&A
Many physicians prefer tirzepatide over semaglutide due to its superior efficacy in weight loss and A1c reduction but factors like insurance...